US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

YS

YS Biopharma (YS)

YS Biopharma Company Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:YS

Fecha	Hora	Fuente	Título	Símbolo	Compañía
07/11/2024	07:00	GlobeNewswire Inc.	LakeShore Biopharma Initiates Biologics License Application of PIKA Rabies Vaccine to the Drug Regulatory Authority of Pakistan	NASDAQ:YS	YS Biopharma Company Ltd
24/05/2024	06:30	PR Newswire (US)	YS Biopharma Announces Name Change to LakeShore Biopharma	NASDAQ:YS	YS Biopharma Company Ltd
21/05/2024	15:15	PR Newswire (US)	YS Biopharma Announces Results of Extraordinary General Meeting	NASDAQ:YS	YS Biopharma Company Ltd
07/05/2024	15:20	PR Newswire (US)	YS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive Officer	NASDAQ:YS	YS Biopharma Company Ltd
29/04/2024	07:00	PR Newswire (US)	YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule	NASDAQ:YS	YS Biopharma Company Ltd
19/04/2024	06:00	PR Newswire (US)	YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024	NASDAQ:YS	YS Biopharma Company Ltd
18/04/2024	07:00	PR Newswire (US)	YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
16/04/2024	07:00	PR Newswire (US)	YS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024	NASDAQ:YS	YS Biopharma Company Ltd
09/04/2024	07:00	PR Newswire (US)	YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
03/04/2024	07:00	PR Newswire (US)	YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility	NASDAQ:YS	YS Biopharma Company Ltd
05/03/2024	07:00	PR Newswire (US)	YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries	NASDAQ:YS	YS Biopharma Company Ltd
22/02/2024	16:00	PR Newswire (US)	YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024	NASDAQ:YS	YS Biopharma Company Ltd
18/02/2024	03:30	PR Newswire (US)	/C O R R E C T I O N -- YS Biopharma Co., Ltd./	NASDAQ:YS	YS Biopharma Company Ltd
16/02/2024	19:20	PR Newswire (US)	YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting	NASDAQ:YS	YS Biopharma Company Ltd
14/02/2024	07:00	PR Newswire (US)	YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance	NASDAQ:YS	YS Biopharma Company Ltd
14/02/2024	06:50	PR Newswire (US)	YS Biopharma Announces Appointment of New Directors	NASDAQ:YS	YS Biopharma Company Ltd
12/02/2024	07:50	PR Newswire (US)	YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.	NASDAQ:YS	YS Biopharma Company Ltd
09/02/2024	05:30	PR Newswire (US)	YS Biopharma Announces US$40 Million Private Placement Financing	NASDAQ:YS	YS Biopharma Company Ltd
08/02/2024	17:10	PR Newswire (US)	Shareholders of YS Biopharma Announce an Extraordinary General Meeting	NASDAQ:YS	YS Biopharma Company Ltd
22/01/2024	16:00	PR Newswire (US)	YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024	NASDAQ:YS	YS Biopharma Company Ltd
08/01/2024	07:00	PR Newswire (US)	YS Biopharma Announces Changes to its Board Committees	NASDAQ:YS	YS Biopharma Company Ltd
20/12/2023	15:30	PR Newswire (US)	YS Biopharma Responds to Unauthorized Press Release Regarding Extraordinary General Meeting	NASDAQ:YS	YS Biopharma Company Ltd
20/12/2023	07:56	PR Newswire (US)	YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023	NASDAQ:YS	YS Biopharma Company Ltd
14/11/2023	07:30	PR Newswire (US)	Noble Capital Markets Initiates Coverage on YS Biopharma With Outperform Rating and US$5.25 Price Target	NASDAQ:YS	YS Biopharma Company Ltd
31/10/2023	07:30	PR Newswire (US)	YS Biopharma Announces Completion of Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
26/10/2023	07:30	PR Newswire (US)	YS Biopharma Announces Receipt of Nasdaq Notice	NASDAQ:YS	YS Biopharma Company Ltd
26/09/2023	07:30	PR Newswire (US)	YS Biopharma Announces First Subject Enrollment in Pivotal Phase 3 Clinical Trial of PIKA Rabies Vaccine	NASDAQ:YS	YS Biopharma Company Ltd
15/09/2023	07:30	PR Newswire (US)	YS Biopharma Granted Patent in the U.S. for Immunotherapy Targeting Chronic Hepatitis B Virus Infection	NASDAQ:YS	YS Biopharma Company Ltd
05/09/2023	07:30	PR Newswire (US)	YS Biopharma to Participate in Participate in Citi's 18th Annual Biopharma Conference	NASDAQ:YS	YS Biopharma Company Ltd
24/08/2023	15:15	PR Newswire (US)	YS Biopharma Announces Purchase of Shares by Company Officers	NASDAQ:YS	YS Biopharma Company Ltd

Showing the most relevant articles for your search:NASDAQ:YS

Deutsche Telekom (QX)

Health Care Select Sector

Gold vs US Dollar

Energy Select Sector SPDR

American Express

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones